Ferric pyrophosphate: good things come to those who wait?
Lisa H Fell, Danilo Fliser, Gunnar H Heine
Abstract
…we have to keep in mind that we generally lack data from adequately powered clinical trials on the benefits and risks of i.v. iron supplementation in CKD. The rise and fall of ESAs taught us that any treatment strategy for anemia of CKD must be tested in adequately designed clinical trials which do not focus on surrogates such as changes in hemoglobin levels, but on clinical end-points. …